RxDoctor Payments Data

Amol Malankar

Family Medicine · Miami, FLNPI 1134548241

Payments from drug & device makers

$755,317in general payments, 2019–2025

Across 99 payments — averaging $7629.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$217K
  • AbbVie$210K
  • Regeneron$162K
  • Shire North American Group Inc$74K
  • Sage Therapeutics, LLC$61K
  • Takeda Pharmaceuticals U.S.A., Inc.$28K
  • plus $3K from 4 others

What the payments were for

  • Food & beverage$416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$755,317 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst87$1,018
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$232
Prednisone16$42
Amlodipine Besylate12$29

Paid to pharmacies, not to this prescriber.

Other family medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →